3/10/23 *UPDATE*
Greetings Readers,
Good morning. It’s Friday! Let’s dive right into it.
Over the past few days, we’ve been following (BCAN), a Nasdaq profile that has shown impressive short-term growth.
Starting at $3.31 on March 8th, it reached a high of $4.54 the next day, resulting in an approximate 37%, 2-day increase.
During after-hours on Wednesday, the company surged to $5.20, an approximate 57% increase from its opening price that same day.
Today, we need to keep our focus on this company for three reasons.
Firstly, it recently filed for a U.S. patent for AI-based technology in the multi-bn dollar sextech industry.
Secondly, it remains above four key lines of potential support, including its 5-Day Exponential Moving Average (EMA) and 13-Day EMA.
Lastly, it is a low float profile with only 1.13Mn shares according to Yahoo Finance.
Don’t miss out on getting (BCAN) front and center again this morning.
Stay tuned for more updates.
Sincerely,
Virtus Junxit
3/9/23 *UPDATE*
Greetings Readers,
BCAN put together a solid session yesterday. Let’s do a quick deep dive before the bell.
First off, BCAN made a huge announcement during pre-market Wednesday. Check it out here: U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the MultiBn-Dollar Sextech Industry
Yftah Ben Yaackov, CEO and Director of BYND Cannasoft shared, “Our new AI based device comes at a pivotal time as most companies are changing their focus to connect with their customers in more automated and personalized ways. Real-time technologies and generative AI are paving the way for how consumers think and influencing the items they purchase. BYND Cannasoft intends to pursue the final registration of its patents and establish a marketing and sales system for our new AI device and the EZ-G device based on B2B and B2C sales.”
On the heels of that awesome news, BCAN took flight.
Opening at $3.31, barely any time passed before it rocketed up to a $4.02 high.
When it reached that level, also a new 2023 high for BCAN, it represented an intraday surge of approximately 21%.
By the time the closing bell rolled around, BCAN had firmly planted itself above 4 key lines of potential support including its:
- 5-Day Exponential Moving Average (EMA)
- 13-Day EMA
- 20-Day Simple Moving Average (SMA)
- 50-Day SMA
If potential support swells at those key levels this week, it could help provide the building blocks for BCAN to try and create another new 2023 high near term.
Take a second to get BCAN on your radar again this morning. When updates show up, I’ll have them out to you quickly.
Sincerely,
Virtus Junxit
3/8/23 *2ND Midday Update*
Greetings Readers,
BCAN is showing itself to be relentless this morning.
With a recent surge, it is now up approximately 18% after reaching an early day high of $3.98.
Could $4.00 potential resistance be in BCAN’s sights this morning?
Remember, today the company dropped this huge news: U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the MultiBn-Dollar Sextech Industry
With help from the news, BCAN is now firmly trading above 4 key lines of potential support including its:
- 5-Day Exponential Moving Average (EMA)
- 13-Day EMA
- 20-Day Simple Moving Average (SMA)
- 50-Day SMA
Time’s ticking to get this low float Nasdaq idea on radar. If more updates are necessary today, I’ll alert you quickly.
Sincerely,
Virtus Junxit
3/8/23 *Midday Update*
Greetings Readers,
BCAN is humming early. Have it on radar?
If not, now is the time to pull up this low float Nasdaq idea as it is making early green moves and just hit a high of $3.58 so far.
Part of the reason for this early burst is the company made a huge announcement during pre-market. Read this:
U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the MultiBn-Dollar Sextech Industry
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & In-vest-ments LTD. filed US Provisional Patent Application 63/450,503 on March 7, 2023 covering the mechanical structure, operation, and controlling aspects of an additional smart female treatment device
ASHKELON, Israel and VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today plans to enter the multiBn-dollar Sextech Industry as its Zigi Carmel Initiatives & In-vest-ments subsidiary filed a U.S. Provisional Patent Application for an additional smart female treatment device for external use. The new artificial intelligence (AI) based device will be capable of treating certain phenomena in female sexual organs. Sextech is a $30Bn industry today, however, according to an analysis report, the industry should grow to $52.7Bn by 2026 with a huge assist from online sales. The company plans to develop the new AI based device as well as its EZ-G device.
The device utilizes an artificial intelligence and machine learning algorithms to control the operational parameters of the device based on physiological parameters of the user. The device performs operations including stimulating the sexual organs based on user preferences as well as real time data indicative of satisfaction level of the user monitored by sensors. The patent application covers AI that stores user preference data and uses that data to learn general preferences and current operation preferences. This AI component will collect data on the response to various operation parameters and adjust the user preference data accordingly to provide learning capabilities and fine tune its operation as it gets to know its user.
…
Yftah Ben Yaackov, CEO and Director of BYND Cannasoft said, “Our new AI based device comes at a pivotal time as most companies are changing their focus to connect with their customers in more automated and personalized ways. Real-time technologies and generative AI are paving the way for how consumers think and influencing the items they purchase. BYND Cannasoft intends to pursue the final registration of its patents and establish a marketing and sales system for our new AI device and the EZ-G device based on B2B and B2C sales.“
…
But the news isn’t the only thing to focus on. With BCAN heating up early, it has moved above 4 key lines of potential support. Check them out:
- 5-Day Exponential Moving Average (EMA)
- 13-Day EMA
- 20-Day Simple Moving Average (SMA)
- 50-Day SMA
If potential support starts growing significantly at those levels, it could act as the building blocks for BCAN to try and run down previous highs.
Take a second now to pull up BCAN. If more updates pop up today, I’ll get them out quickly. Talk soon.
Sincerely,
Virtus Junxit
3/8/23
Greetings Readers,
Talk about closing out February with one last killer.
Follow me for a sec, so I can get everything recapped quickly.
Last Monday, February 27th, my alert came on to the scene and made quick work of the markets.
The next morning saw it jump from an open of $4.18 to a high of $5.74 by March 7th.
That approximately surge of $1.50+ helped it to reach a new 52-week high.
At the same time, the approximately 37% run resulted in that Nasdaq profile joining a sturdy list of breakout runners we’ve alerted over the last 6 months.
But now it’s March and it’s time to step it up into full gear.
I’ve got another Nasdaq breakout idea that’s currently flying below Wall Street’s radar, but it might start to draw a ton of attention near term. Here’s why.
Based on its tiny float (fewer than 2Mn shares), it trading above several lines of potential support, a unique license from the Israel’s Ministry of Health, and key patent news, it could be ready to catch the market off guard.
Right now, it’s time to get this Nasdaq profile on radar:
BYND Cannasoft Enterprises Inc. (BCAN)
Here are the most important BCAN company details to soak in this second…
The Global Artificial Intelligence (AI) Market is Expected to Reach a Staggering $1.5Tn by 2030. (1)
The global artificial intelligence market has grown rapidly in recent years due to digital technology and heavy in-vest-ments by tech giants.
According to market research, the market size of AI is expected to reach $1.5Tn by 2030, with a registered CAGR of 38.1% from 2022 to 2030.
The North American artificial intelligence market was valued at $147.58Bn in 2021, accounting for 43% of the market share in 2022.
The Asia Pacific market is expected to grow at the highest CAGR of 42% from 2022 to 2030. The use of AI in various industries such as automotive, healthcare, banking & finance, manufacturing, food and beverages, logistics, and retail is expected to significantly drive the growth of the global artificial intelligence market in the forthcoming years.
In the adult toy industry, AI and wearable sex toys have the potential to revolutionize the market, which is expected to be worth $62.32Bn by 2030. (2)
One company to keep an eye on in the AI-powered sex toy market is BYND Cannasoft Enterprises Inc. (BCAN).
BYND Cannasoft Enterprises Inc. Enters $62Bn Market With Filing of US Provisional Patent Application and Full Scale PCT Application for Its AI-Connected EZ-G Device (3)
On January 17, 2023, BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) announced that in addition to the US Provisional Patent Application with serial number 63/297,009 that was filed on January 6, 2022, covering the monitoring and controlling aspects of its EZ-G device, the company filed a full-scale PCT application on January 5, 2023, under serial number PCT/IL2023/050016.
The PCT application is based on BYND Cannasoft’s prototype of the EZ-G device that is currently under development and its operational aspects as a learning adult device. The PCT application further claims priority from the US Provisional application and covers an adult device with a structure and one or more moving and vibrating elements.
In addition to potentially treating annoying phenomena in the female reproductive system, the EZ-G device includes technological advancements as a sex toy with a more realistic experience. The EZ-G device prototype uses sensors like a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor to determine what specifically enhances the users’ pleasure.
The EZ-G device uses artificial intelligence (AI) to transmit and receive data from the device’s sensors on conditions of the user’s sexual organs, such as moisture levels and pressure variations due to muscle contraction. The EZ-G prototype includes a Bluetooth component for controlling the adult device via an app installed on a smartphone or other portable device to collect user information about preferences and generate custom programs.
The data collected from the sensors is uploaded to the secured cloud, where it is combined with other antonymic user preferences, including the actual duration of operation of the adult device, lubrication level, and the ideal vibration level.
This information optimizes the operation of the device to satisfy the user sexually. The EZ-G device uses the collected secure data to learn the users’ responses and improve its operation to bring the user sexual satisfaction.
Wearable tech has seen tremendous growth in recent years. When most people think of wearables, they think of fitness trackers and smartwatches, but there is also an emerging trend in wearable sex toys.
The excitement of a sex toy and the thrill of clandestine public stimulation have contributed to this trend. Cannasoft intends to take advantage of the growth in the sextech market, which is expected to reach $62.32Bn by 2030.
According to Forbes, companies are working to innovate products that have an intelligent response to sexual activity to take advantage of this expected growth.
Yftah Ben Yaackov, CEO and Director of BYND Cannasoft said:
“The EZ-G device has evolved to provide treatment relief from sexual and mental problems, including the ability to have intercourse as it relates to anxiety and physical pain. The device is capable of enhancing sexual pleasure and reducing sexual pain by dispensing low concentrations of C-B-D oil lubricant in a controlled manner. It could be configured to use disposable capsules that include the C-B-D lubricant, which could be dispensed in accordance with data collected by the sensors. The sale of the disposable capsules containing the C-B-D lubricant would provide BYND Cannasoft with a revenue model much like the razor and the razor blade.“
Find more key company details here.
—–
3 Potential Breakout Catalysts To Know Now – Key Details On BCAN
#1. A tiny float could provide the recipe for explosive volatility.
Let’s get straight to it. Yahoo Finance is reporting BCAN to have a very low float.
In fact, the website says BCAN has a float of approximately 1.13Mn shares.
Of all the profiles we’ve delivered, this is definitely one of the smallest floats.
So why is that important to take note of? Simple.
When a float is small like this, the potential for volatility should be extremely significant.
It’s part of the reason BCAN was able to make a move from a 9/16/22 open of $4.10 to the following session’s $16.38 high.
That’s a $12.00+ run and 299% in the blink of an eye! Now that’s what I call a volatile move.
Now, do I think that same move is going to happen this week? Nothing is certain, but the potential needs to be noted.
—–
#2. Crazy asset growth (494%) in 2022 provides a clear picture this company is for real.
Check out this PR:
Israeli Cann-a-bis Technology Company BYND Cannasoft Enterprises Inc. Announces Third Quarter 2022 Fi-nan-cial Results
Company reports 494% growth in 2022 assets to $33Mn USD and strengthened balance sheet while increasing gross margins and reducing losses
VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”), has released its financial results for the nine-month period ended September 30, 2022. Full versions of BYND’s unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedar.com.
Q3 2022 Financial Highlights:
- Revenue increased 10% to $227+k for the three-month period ended September 30, 2022 from $207+k for the previous quarter
- Gross Profit increased to 58% for the nine-month period ended September 30, 2022 from 49% for the same period in 2021.
- Net loss decreased 79% to $964+k for the nine-month period ended September 30, 2022 from $4.5+Mn for the same period in 2021.
- Working capital decreased to $3.1+Mn for September 30, 2022 from $5.4+Mn for December 31,2021.
- Total assets increased to $44.4+Mn for September 30, 2022 from $7.4Mn for December 31,2021.
- Total shares outstanding as of September 30, 2022 were 37.7+Mn.
…
Mr. Yftah Ben Yaackov, BYND’s CEO noted that “We are very pleased with the fi-nan-cial results of the Company during the first nine months of 2022 as we have continued our trend from prior periods of increasing gross margins while decreasing overall losses. We have strengthened our balance sheet with the acquisition of Zigi Carmel Initiatives and In-vest-ments Ltd. and believe the EZ-G device will create significant value for our shareholders.”
—–
#3. A unique license could provide (BCAN) with a new pathway to significant revenue.
Review this quickly:
Israel’s Ministry of Health, through the Medical Cann-a-bis Unit, announced today that it has granted BYND Cannasoft Enterprises Inc.’s Subsidiary, Cannasoft Pharma, a License
Vancouver, British Columbia and Ashkelon, Israel – TheNewswire – February 6, 2023 – BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) (“BYND Cannasoft” or the “Company”) announced today that it received a license to engage in medical cann-a-bis (“CB”) without direct contact with the substance from the Medical CB Unit at the Ministry of Health of the State of Israel. Cannasoft received this license that allows trading in medical CB products through an agreement with a licensed CB grower in Israel.
The standardization of the medical CB field in Israel is among the first in the world. It is an innovative and original process utilizing considerable efforts to provide medical care according to a regulated medical method and practice.
The Medical CB Unit at the Ministry of Health of the State of Israel has set high standards in the field of medical CB in Israel to shorten waiting times and makes the service and procurement of CB products accessible to patients.
The Company has a penetration strategy for the medical CB products market in Israel, which currently has about 150,000 users with an annual sales volume of about half a Bn dollars. BYND Cannasoft intends to capture a market share of about 3%, worth about $15Mn in sales, within a year of putting its products on store shelves.
Yftah Ben Yaackov, CEO and Director of BYND, said, “We are excited to receive the unique license that allows trading in medical CB products under the company brand. The Israeli market is a significantly growing market and the field of medical CB generates hundreds of Mn’s of dollars a year. Our strategy will be to penetrate the CB products market in Israel and globally immediately after the approval of the Israeli regulator for the export of CB products from Israel. Our business plan allows us to accomplish this without investing heavily in resources and establishing and operating cultivation facilities.” Mr. Yaackov continued, “In this way, BYND Cannasoft will be able to realize its goal of generating significant revenues from the sale of CB products while saving significantly on the Company’s expenses for this purpose.“
—–
As I said above, time’s ticking. Drop everything right now to make sure BYND Cannasoft Enterprises Inc. (BCAN) is at the top of your watch-list this AM.
If any updates pop up today, I’ll have them out to you quickly. Talk soon.
Sincerely,
Virtus Junxit
